GW Pharma Expects FDA Decision on Epidiolex in Mid-2018



GW Pharmaceuticals plc Reports Fiscal Fourth Quarter 2017 and Year-End Financial Results and Operational Progress
by

Leave a Reply

Your email address will not be published. Required fields are marked *